Volume 61, Issue 6, Pages (June 2012)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
The PSA Era is not Over for Prostate Cancer
Volume 51, Issue 2, Pages (February 2007)
Volume 60, Issue 2, Pages (August 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Volume 53, Issue 4, Pages (April 2008)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Volume 53, Issue 5, Pages (May 2008)
Let the Games Begin (with EAU Approval)
Volume 71, Issue 5, Pages (May 2017)
Prostate Cancer Epidemic in Sight?
Volume 65, Issue 6, Pages (June 2014)
Volume 72, Issue 5, Pages (November 2017)
Volume 62, Issue 6, Pages (December 2012)
Volume 63, Issue 4, Pages e53-e56 (April 2013)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 189, Issue 1, Pages S45-S50 (January 2013)
Volume 71, Issue 1, Pages 1-3 (January 2017)
Prostate Cancer Detection: A View of the Future
Volume 74, Issue 1, Pages (July 2018)
Next-generation Sequencing of Urologic Cancers: Next Is Now
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 6, Pages (June 2016)
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
Laurent Boccon-Gibod  European Urology Supplements 
Volume 73, Issue 2, Pages (February 2018)
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
Volume 68, Issue 3, Pages (September 2015)
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 53, Issue 6, Pages (June 2008)
Leonard S. Marks, Jiaoti Huang  European Urology 
Volume 53, Issue 4, Pages (April 2008)
Volume 62, Issue 4, Pages (October 2012)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 68, Issue 6, Pages e134-e135 (December 2015)
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
The Economic Costs of Overactive Bladder in Germany
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
RANK Ligand-targeted Therapy: A Novel Approach to Prevent Bone Loss and Fractures in Men with Prostate Cancer  Matthew R. Smith  European Urology Supplements 
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Testicular Cancer Variations in Time and Space in Europe
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Volume 59, Issue 4, Pages (April 2011)
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Improving Flexibility and Quality of Life for Your Patients: A Must?
Volume 53, Issue 6, Pages (June 2008)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 51, Issue 2, Pages (February 2007)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 61, Issue 6, Pages 1119-1128 (June 2012) Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous Thromboembolism  Jim C. Hu, Stephen B. Williams, A. James O'Malley, Matthew R. Smith, Paul L. Nguyen, Nancy L. Keating  European Urology  Volume 61, Issue 6, Pages 1119-1128 (June 2012) DOI: 10.1016/j.eururo.2012.01.045 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Derivation of the study cohort, peripheral artery disease, and venous thromboembolism. PCa=prostate cancer; Dx=diagnosis; PAD=peripheral artery disease; VTE=venous thromboembolism. European Urology 2012 61, 1119-1128DOI: (10.1016/j.eururo.2012.01.045) Copyright © 2012 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.